📰 6 sources covering this story

AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report

First covered 4 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

The deal could create one of the world's biggest pharmaceutical groups with a combined value of nearly $400 billion.

Fortune1 hrs ago

Bristol Myers Squibb, which has a $133 billion market capitalization, could provide AstraZeneca with a bigger foothold in the US market.

The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly US$400 billion.

CNBC2 hrs ago

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

Reuters2 hrs ago

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports Reuters

Financial Times🏁 first to report4 hrs ago

Tie-up would create one of the world’s biggest drugmakers